BioCentury
ARTICLE | Clinical News

Medarex preclinical data

May 4, 2009 7:00 AM UTC

MDX-1204, a human antibody against mesothelin conjugated to a DNA alkylating agent, had significant anti-tumor activity and was well tolerated in monkey and mouse models of lung cancer. Data were pre...